Anti-Cancer API CAS114977-28-5 Docetaxel Powder with Best Price

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: 102402
• Certification: ISO 9001, USP
• Suitable for: Adult
• State: Solid
• Purity: >99%
• Appearance: White Powder
• Molecular Formula: C43h53no14
• MW: 807.88
• CAS No.: 114977-28-5
• Einecs No: 601-339-2
• Storage: Cool Dry Area
• Shelf Life: 24 Months
• Sample: Avaliable
• Brand: Tgy
• MOQ: 1kg
• Assay: 99%Docetaxel
• COA: Available
• Grade: Pharmaceutical Grade
• Test Method: UV/HPLC
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China
• HS Code: 29322090
• Production Capacity: 260kg/Month

Product Description

Anti-Cancer API CAS114977-28-5 Docetaxel powder with best price

 

Product Name	Anti-Cancer API CAS114977-28-5 Docetaxel powder with best price
CAS No	114977-28-5
MOQ	1kg
Color	White powder
Purity	99%
Certificate	FDA; ISO9001;SGS; COA

 
Docetaxel is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumor including breast and lung cancer. Therapy with docetaxel has been associated with a low rate of serum enzyme elevations and rarely to instances of acute hepatic necrosis generally due to severe hypersensitivity reactions or sepsis. 

Don't hesitate to contact us for latest COA and HPLC Test Report 

1.Docetaxel is a clinically well established antimitotic chemotherapy medication (that is, it interferes with cell division).

 

2.Docetaxel is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.

 

3.Docetaxel has an FDA approved claim for treatment of patients who have locally  advanced, or metastatic  breast or non small cell lung cancer who have undergone anthracycline based chemotherapy and failed to stop cancer progression or relapsed. An European approval  docetaxel for use in hormone refractory 

prostate cancer. 

 

4.Docetaxel is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule.